Coupang Total Cost of Revenue decreased by 1.3% to $6.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.0%, from $5.59B to $6.21B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 12.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.82B | $3.89B | $4.27B | $4.07B | $3.88B | $3.87B | $4.05B | $4.38B | $4.31B | $4.62B | $4.88B | $5.19B | $5.18B | $5.60B | $5.47B | $5.59B | $5.96B | $6.55B | $6.29B | $6.21B |
| QoQ Change | — | +1.8% | +9.8% | -4.6% | -4.6% | -0.4% | +4.7% | +8.2% | -1.5% | +7.0% | +5.7% | +6.3% | -0.1% | +8.0% | -2.2% | +2.2% | +6.6% | +9.8% | -3.9% | -1.3% |
| YoY Change | — | — | — | — | +1.7% | -0.6% | -5.2% | +7.6% | +11.1% | +19.4% | +20.5% | +18.4% | +20.1% | +21.2% | +12.2% | +7.8% | +15.1% | +17.0% | +14.9% | +11.0% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Product Commerce | $4.72B | $4.94B | $5.42B | $5.05B | $5.00B |
| Developing Offerings | $873.00M | $1.02B | $1.13B | $1.24B | $1.21B |
| Total | $5.59B | $5.96B | $6.55B | $6.29B | $6.21B |